Carlos joined CTTC in March 2024 and is responsible for commercializing life science technologies. Prior to joining CTTC, Carlos finished his doctoral thesis establishing a mouse model in which scientists can track tumor-specific CD8 T cells response against various stages of tumorgenesis. His work shows that identifying patients at high-risk for cancer and administering cancer vaccines early, before macroscopic lesions have developed, may lead to improved and longer-term responses. He also completed an internship at our office in 2023.
Carlos received his B.S. in Biology from University of Puerto Rico, Aguadilla and his Ph.D. in Cancer Biology from Vanderbilt University.
Academic degree:
Ph.D.
Job title:
Licensing Analyst
Portrait:
Phone number:
615.343.6197
E-mail address:
External Profile: